Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 946 of 6351
-
New hope for blood cancer patients: triple therapy aims to keep disease in check longer
Disease control OngoingThe purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up …
Phase 3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail targets tough cancers in early trial
Disease control CompletedBackground: Small cell lung cancer and PARP inhibitor resistant tumors are aggressive cancers. Current treatments for people with these tumors yield little benefit. Researchers want to see if a combination of drugs can help. Objective: To find a safe combination of sacituzumab…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for kids with tough cancers: personalized cell therapy trial launches
Disease control Recruiting nowA Phase I open-label, multicenter study, to evaluate the safety, feasibility, and maximum tolerated dose (MTD) of treating children with newly diagnosed DIPG or recurrent neuroblastoma with molecular targeted therapy in combination with adoptive cell therapy (Total tumor mRNA-pul…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for seniors with aggressive blood cancer: targeted combo shows promise
Disease control OngoingThe purpose of this study is to test the effectiveness and safety of polatuzumab vedotin in combination with R-miniCHP in patients 75 years and older with DLBCL.
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could donor immune cells beat COVID-19? new trial begins.
Disease control Recruiting nowThe 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with a current death toll of \>300,000 and climbing.4 There is no accepted standard o…
Phase 1/2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a new injection strategy help men with Peyronie's disease who failed standard treatment?
Disease control CompletedCompare key clinical outcomes between controls and men treated with a novel CCH administration protocol among men previously unresponsive to CCH administration.
Phase 4 • Sponsor: Charitable Union for the Research and Education of Peyronie's Disease • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A new weapon against birth tears? pelvic floor training put to the test
Prevention CompletedThis prospective randomized clinical trial evaluates whether targeted deep pelvic floor muscle physiotherapy is more effective than standard antenatal perineal massage in reducing perineal trauma among nulliparous women. The study compares the effects of these two antenatal inter…
Sponsor: Meir Medical Center • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
New study tests best ways to get opioid treatment to those who need it
Disease control CompletedThis study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation …
Phase 2/3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Brain scan guided magnetic pulses aim to beat depression
Symptom relief Recruiting nowRepetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting sta…
Phase 3 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New hope for pancreatic cancer: drug combo shows promise in early trial
Disease control OngoingPhase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma.
Phase 1/2 • Sponsor: Alligator Bioscience AB • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could young Athletes' plasma slow Alzheimer's? new study tests the idea
Disease control OngoingIntroduction Given that exercise training reduces the risk of developing Alzheimer's disease (AD), induces changes in the blood composition and has widespread systemic benefits, it is reasonable to hypothesize that exercised plasma may have rejuvenative properties. The main objec…
Phase 2 • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill targets rare gene mutations in advanced cancers
Disease control OngoingAn Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of KL590586 Capsules In Patients With Advanced Solid Tumors Carrying RET Fusion Or Mutant Genes
Phase 1/2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of Sintilimab plus anlotinib combined with chemotherapy as neoadjuvant therapy in participants who have triple negative breast cancer (TNBC). After a screening phase of approximately 28 days, each participant will r…
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a Parent's hamstring tendon rebuild a Child's torn ACL?
Disease control Recruiting nowThe Anterior Cruciate Ligament (ACL) is a major stabiliser of the knee. ACL rupture is being increasingly identified in children and skeletally immature patients. The current advice in younger patients is usually to undergo ACL reconstruction. The choice of an ideal graft in chil…
Sponsor: Maidstone & Tunbridge Wells NHS Trust • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New pill aims to stop Narcolepsy's sudden muscle weakness
Symptom relief CompletedThis study is a multi-center, double-blind, placebo-controlled, randomized Phase 3 trial to assess the safety and efficacy of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Fighting stigma to stop HIV: a new counseling approach put to the test
Prevention CompletedThe proposed research aims to assess the multiple forms and paths of stigma and substance use as they relate to pre-exposure prophylaxis (PrEP) use for HIV prevention. How stigma and an evolving public health landscape impact PrEP use among Black sexual minorit men who use substa…
Sponsor: University of Connecticut • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Nanoparticles boost radiation against tough brain tumors
Disease control Recruiting nowThe purpose of this study is to determine whether AGuIX (Activation and Guidance of Irradiation by X-ray) gadolinium-based nanoparticles make radiation work more effectively in the treatment of patients with brain metastases that are more difficult to control with stereotactic ra…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 10, 2026 06:00 UTC
-
Could a One-Time ketamine infusion tame cluster headaches?
Symptom relief CompletedChronic cluster headache (CCH) is a rare primary headache disorder, defined by episodic attacks that occur for more than one year with no remission period or with remission periods lasting \< 3 months (ICHD-3 criteria). In certain cases, CCH patients become drug-resistant and con…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New blood filter shows promise for liver failure patients
Disease control OngoingAcute-on-chronic liver failure (ACLF) is a life-threatening syndrome occurring in patients with chronic liver disease. In China, hepatitis B virus (HBV) is the main cause of cirrhosis. HBV related ACLF is characterized by multiple organs failure (liver, coagulation and kidney, et…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could extra white cells boost immune recovery in kids with tough leukemia?
Disease control OngoingAlthough most children with leukaemia are cured using drugs (chemotherapy) alone, for some children additional treatments are needed. Stem cell transplant can cure children where chemotherapy and other drugs have failed. In this case, the immune cells of the donor attack the leuk…
Sponsor: University of Manchester • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC